Prime Medicine, Inc. (PRME)
3.65
+0.06
(+1.67%)
USD |
NASDAQ |
Sep 01, 12:59
Prime Medicine Cash from Operations (TTM) : -156.05M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -156.05M |
| March 31, 2026 | -156.42M |
| December 31, 2025 | -162.56M |
| September 30, 2025 | -109.06M |
| June 30, 2025 | -99.94M |
| March 31, 2025 | -104.02M |
| December 31, 2024 | -122.86M |
| September 30, 2024 | -182.97M |
| June 30, 2024 | -196.23M |
| March 31, 2024 | -191.56M |
| Date | Value |
|---|---|
| December 31, 2023 | -165.41M |
| September 30, 2023 | -152.26M |
| June 30, 2023 | -143.19M |
| March 31, 2023 | -122.60M |
| December 31, 2022 | -131.83M |
| September 30, 2022 | -114.30M |
| June 30, 2022 | -93.81M |
| March 31, 2022 | -80.00M |
| December 31, 2021 | -34.08M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Beam Therapeutics, Inc. | -359.38M |
| Twist Bioscience Corp. | -53.07M |
| Sana Biotechnology, Inc. | -132.24M |
| Intellia Therapeutics, Inc. | -346.64M |
| Revolution Medicines, Inc. | -1.223B |